Evidence map›Paper›PMID 29845888›Full record

ArticleIntegrative cancer therapies2018

Self-reported Improvement in Side Effects and Quality of Life With Integrative Medicine in Breast Cancer Patients.

Carolin C Hack, Janina Hackl, Nina B M Hüttner, Hanna Langemann, Judith Schwitulla, Svenja Dietzel-Drentwett, Peter A Fasching, Matthias W Beckmann, Anna-Katharin Theuser

Open access · goldAbstract read
In one paragraph

Article in Integrative cancer therapies, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Carolin C Hack1 Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany.ORCID 0000-0002-2426-7020
Janina Hackl1 Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany.
Nina B M Hüttner1 Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany.
Hanna Langemann1 Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany.
Judith Schwitulla1 Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany.
Svenja Dietzel-Drentwett2 Hospital Bayreuth GmbH, Bayreuth, Germany.
Peter A Fasching1 Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany.
Matthias W Beckmann1 Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany.
Anna-Katharin Theuser1 Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany.
Friedrich-Alexander-Universität Erlangen-Nürnberg · DEBayreuth Medical Center · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAlthough the demand from patients for integrative medicine is increasing, complementary medicine services are still quite heterogeneous and have not been incorporated into clinical routine. The aim of this study was to systematically evaluate improvements in side effects and quality of life associated with a hospital-based integrative medicine program in the modern breast cancer patient care setting.

methodsIn a cross-sectional study, integrative health counseling and treatment were evaluated in women with breast cancer. Over a 15-month period, data for 75 patients from an integrative medicine consultancy service with standardized operating procedures were collected at the University Breast Center for Franconia. At baseline, the patients answered a questionnaire on their medical history, symptoms, and the treatment goals they were hoping to achieve with integrative medicine. In the follow-up, patient-reported outcomes related to side effects of conventional cancer treatment and patients' quality of life were analyzed.

resultsAmong 60 patients with the therapy goal of reducing the side effects of conventional treatment, 46 (76.7%) were successful. Among 57 patients hoping to improve disease-related quality of life, 46 (82%) reported success. Whereas patients with metastatic disease achieved a reduction in the side effects of conventional therapy, quality-of-life improvements were predominantly achieved by patients with a good treatment prognosis.

conclusionsBreast cancer patients benefit from the counseling and treatment provided with integrative medicine in all phases of tumor disease. Integrative treatment services should be included as part of patient care in clinical routine work to offer patients the maximum quality of care and safety with complementary therapies.

Indexed as

Quality of LifeAdultAgedBreast NeoplasmsCross-Sectional StudiesDrug-Related Side Effects and Adverse ReactionsFemaleHumansIntegrative MedicineIntegrative OncologyMiddle AgedRetrospective StudiesSelf Reportbreast cancercomplementary and alternative medicineintegrative medicineoncologypatient carequality of lifeside effect management

Identifiers

PMID29845888
PMCPMC6142097
OpenAlexW2806267681

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.